Geode Capital Management’s Sinovac Biotech, Ltd SVA Stock Holding History

Geode Capital Management’s Portfolio SVA Stock Details SVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	27,717	–	–	﹤0.01%	4610
2026 Q1	$0	Hold	27,717	–	–	﹤0.01%	4627
2025 Q4	$0	Hold	27,717	–	–	﹤0.01%	4585
2025 Q3	$0	Hold	27,717	–	–	﹤0.01%	4592
2025 Q2	$0	Buy	+27,717	New	–	﹤0.01%	4592
2024 Q3	–	Sell	-27,717	Closed	-$89.7K	–	4684
2024 Q2	$89.7K	Hold	27,717	–	–	﹤0.01%	4164
2024 Q1	$179K	Buy	+27,717	New	+$179K	﹤0.01%	3979
2023 Q4	–	Sell	-27,717	Closed	-$179K	–	4829
2023 Q3	$179K	Hold	27,717	–	–	﹤0.01%	4026
2023 Q2	$179K	Buy	+27,717	New	+$179K	﹤0.01%	4090
2022 Q4	–	Sell	-27,717	Closed	-$179K	–	5088
2022 Q3	$179K	Hold	27,717	–	–	﹤0.01%	4278
2022 Q2	$179K	Buy	+27,717	New	+$179K	﹤0.01%	4342
2022 Q1	–	Sell	-27,717	Closed	-$179K	–	5096
2021 Q4	$179K	Hold	27,717	–	–	﹤0.01%	4530
2021 Q3	$179K	Hold	27,717	–	–	﹤0.01%	4496
2021 Q2	$179K	Hold	27,717	–	–	﹤0.01%	4381
2021 Q1	$179K	Hold	27,717	–	–	﹤0.01%	4149
2020 Q4	$179K	Hold	27,717	–	–	﹤0.01%	3915
2020 Q3	$179K	Hold	27,717	–	–	﹤0.01%	3748
2020 Q2	$179K	Hold	27,717	–	–	﹤0.01%	3694
2020 Q1	$179K	Hold	27,717	–	–	﹤0.01%	3581
2019 Q4	$179K	Hold	27,717	–	–	﹤0.01%	3831
2019 Q3	$179K	Hold	27,717	–	–	﹤0.01%	3809
2019 Q2	$179K	Hold	27,717	–	–	﹤0.01%	3819
2019 Q1	$179K	Hold	27,717	–	–	﹤0.01%	3764
2018 Q4	$192K	Hold	27,717	–	–	﹤0.01%	3694
2018 Q3	$213K	Hold	27,717	–	–	﹤0.01%	3755
2018 Q2	$206K	Hold	27,717	–	–	﹤0.01%	3708
2018 Q1	$238K	Hold	27,717	–	–	﹤0.01%	3639
2017 Q4	$218K	Hold	27,717	–	–	﹤0.01%	3650
2017 Q3	$195K	Sell	27,717 -6,770	-20%	-$46.2K	﹤0.01%	3682
2017 Q2	$232K	Sell	34,487 -4,989	-13%	-$27.3K	﹤0.01%	3632
2017 Q1	$225K	Buy	39,476 +12,306	+45%	+$71.2K	﹤0.01%	3618
2016 Q4	$160K	Buy	27,170 +3,873	+17%	+$23.3K	﹤0.01%	3687
2016 Q3	$137K	Buy	23,297 +158	+0.7%	+$929	﹤0.01%	3722
2016 Q2	$137K	Hold	23,139	–	–	﹤0.01%	3708
2016 Q1	$147	Sell	23,139 -158	-0.7%	-$949	﹤0.01%	3720
2015 Q4	$133K	Buy	23,297 +316	+1%	+$1.7K	﹤0.01%	3814
2015 Q3	$116K	Buy	22,981 +316	+1%	+$1.67K	﹤0.01%	3861
2015 Q2	$118K	Buy	22,665 +5,166	+30%	+$27.3K	﹤0.01%	3737
2015 Q1	$86K	Buy	17,499 +474	+3%	+$2.33K	﹤0.01%	3781
2014 Q4	$89K	Buy	17,025 +5,845	+52%	+$29.8K	﹤0.01%	3808
2014 Q3	$53K	Buy	11,180 +616	+6%	+$3.31K	﹤0.01%	3833
2014 Q2	$59K	Sell	10,564 -158	-1%	-$960	﹤0.01%	3763
2014 Q1	$77K	Buy	10,722 +474	+5%	+$3.14K	﹤0.01%	3705
2013 Q4	$62K	Buy	+10,248	New	+$61.7K	﹤0.01%	3668

Other funds holding SVA

NAH

Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Horizon Investments Charlotte, North Carolina $9.13B AUM 34.49% 1-Year Est. Return

Geode Capital Management's SVA Position: Q2 2026 in Review

Geode Capital Management held its Sinovac Biotech, Ltd (SVA) position steady in Q2 2026 at 27,717 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4610.

Geode Capital Management first reported a position in SVA in Q4 2013 and has held it in 44 quarters since. The position peaked at $238K in Q1 2018. 20 funds tracked by Wall St. Rank hold SVA as of Q2 2026.

Geode Capital Management held 27,717 shares of Sinovac Biotech, Ltd worth $0 as of Q2 2026.
Geode Capital Management left its Sinovac Biotech, Ltd share count unchanged in Q2 2026.
Sinovac Biotech, Ltd made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4610 holding.
Geode Capital Management first reported a position in Sinovac Biotech, Ltd in Q4 2013 and has held it in 44 quarters since.
Geode Capital Management's Sinovac Biotech, Ltd position peaked at $238K in Q1 2018.
20 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.